Notice: This company has been marked as potentially delisted and may not be actively trading. Mallinckrodt (MNK) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mallinckrodt Completes Divestiture of Therakos® BusinessDecember 2, 2024 | finance.yahoo.comMallinckrodt to Present at Jefferies London Healthcare ConferenceNovember 15, 2024 | uk.finance.yahoo.comMallinckrodt to Report Earnings Results for Third Quarter 2024October 24, 2024 | finance.yahoo.comHudson Bay Capital Management LP Acquires New Stake in Mallinckrodt PLCOctober 22, 2024 | finance.yahoo.comMallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. HospitalsOctober 10, 2024 | finance.yahoo.comMallinckrodt plc: THERAKOS CELLEX Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)September 3, 2024 | finanznachrichten.deMallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year GuidanceAugust 6, 2024 | stockhouse.comCVC Capital to Buy Therakos From Mallinckrodt for $925 MillionAugust 6, 2024 | wsj.comMallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.August 6, 2024 | finance.yahoo.comMallinckrodt plc: Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 MillionAugust 5, 2024 | finanznachrichten.deMallinckrodt to Report Earnings Results for Second Quarter 2024August 1, 2024 | finance.yahoo.comBankruptcy allowed Mallinckrodt to end Acthar royalties, 3rd Circ. rulesApril 25, 2024 | reuters.comMallinckrodt plc: Mallinckrodt Announces 2024 Extracorporeal Immunomodulation AwardApril 14, 2024 | finanznachrichten.deMallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 GuidanceMarch 26, 2024 | finance.yahoo.comMallinckrodt plc: Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty BrandsMarch 4, 2024 | finanznachrichten.deMallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty BrandsMarch 4, 2024 | finance.yahoo.comMallinckrodt Says FDA Grants SNDA For Acthar Gel Single-Dose Pre-Filled SelfJect InjectorMarch 1, 2024 | markets.businessinsider.comMallinckrodt Stock (OTC:MCKPF) Dividends: History, Yield and DatesFebruary 24, 2024 | benzinga.comMallinckrodt plc: Mallinckrodt Presents Data on Real-World Outcomes with THERAKOS CELLEX Photopheresis System Treatment at the 2024 Tandem MeetingsFebruary 21, 2024 | finanznachrichten.deMallinckrodt Announces Executive Appointments and Incentive PlansFebruary 3, 2024 | msn.comMallinckrodt PLC Ordinary Shares - NewJanuary 31, 2024 | morningstar.comMallinckrodt to discontinue StrataGraft due to slow uptakeJanuary 9, 2024 | msn.comMallinckrodt Earns Top Score in Human Rights Campaign Foundation's 2023-2024 Corporate Equality IndexDecember 27, 2023 | finance.yahoo.comMallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of the INOmax® (nitric oxide) Mini-CylinderDecember 7, 2023 | sg.finance.yahoo.comMallinckrodt Avoids $40 Million SEC Fine in Medicaid Overcharge CaseDecember 1, 2023 | msn.comMallinckrodt plc (in Examinership) Reports Third Quarter 2023 Financial ResultsNovember 16, 2023 | finance.yahoo.comMallinckrodt emerges from bankruptcyNovember 15, 2023 | msn.comMallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11November 14, 2023 | finance.yahoo.comMallinckrodt sees emerging from Chapter 11 by end of yearOctober 11, 2023 | msn.comMallinckrodt Bankruptcy Plan Gets Approval, Will Wipe Out $1 Billion in Opioid PaymentsOctober 11, 2023 | msn.comMallinckrodt Approved to End Bankruptcy, Reduce Opioid PaymentsOctober 11, 2023 | finance.yahoo.comMallinckrodt gets court approval for restructuring, $1 bln cut to opioid settlementOctober 10, 2023 | reuters.comMallinckrodt plc (in examinership) Receives U.S. Court Approval for Financial Restructuring PlanOctober 10, 2023 | finance.yahoo.comFirm Retention Summary: MallinckrodtSeptember 20, 2023 | msn.comDrug giant Mallinckrodt enters second Irish ExaminershipSeptember 20, 2023 | msn.comBankrupt Drugmaker Mallinckrodt Considers Sale of Opioid BusinessSeptember 19, 2023 | msn.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)September 1, 2023 | benzinga.comMallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)August 31, 2023 | finance.yahoo.comMallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing OperationsAugust 30, 2023 | finance.yahoo.comMallinckrodt files for bankruptcy for a second timeAugust 28, 2023 | msn.comNYSE American to Commence Delisting Proceedings Against Mallinckrodt plc (MNK)August 28, 2023 | finance.yahoo.comMallinckrodt bankruptcy shows millions owed to NC firms, stateAugust 28, 2023 | bizjournals.comMallinckrodt discloses grand jury subpoena, makes bankruptcy filing officialAugust 28, 2023 | msn.comHit By Opioid Lawsuits Mallinckrodt Files For Second Bankruptcy In Just Three YearsAugust 28, 2023 | msn.comDrug maker Mallinckrodt again files for bankruptcy, as plannedAugust 28, 2023 | bizjournals.comCalling All Mallinckrodt plc (MNK) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your LossesAugust 28, 2023 | benzinga.comMallinckrodt Initiates Voluntary Prepackaged Chapter 11 Proceedings In U.S. Bankruptcy CourtAugust 28, 2023 | nasdaq.comDrugmaker Mallinckrodt files for second bankruptcy in the USAugust 28, 2023 | msn.comMallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid ObligationsAugust 28, 2023 | finance.yahoo.comMallinckrodt Lenders to Take Control in Bankruptcy That Cuts $1 Billion in Opioid PaymentsAugust 24, 2023 | msn.com Get Mallinckrodt News Delivered to You Automatically Sign up to receive the latest news and ratings for MNK and its competitors with MarketBeat's FREE daily newsletter. Email Address Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. MNK Media Mentions By Week MNK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNK News Sentiment▼0.000.60▲Average Medical News Sentiment MNK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNK Articles This Week▼00▲MNK Articles Average Week Get Mallinckrodt News Delivered to You Automatically Sign up to receive the latest news and ratings for MNK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EDSA News Today AIMD News Today CNSP News Today GTBP News Today SYRS News Today HOTH News Today CANF News Today ELAB News Today PPBT News Today AEZS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MNK) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mallinckrodt plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mallinckrodt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
